Viruela del simio: ¿estamos frente a un riesgo de pandemia?. Historia de un viejo conocido
DOI:
https://doi.org/10.18041/2665-427X/ijeph.2.8803Palabras clave:
Viruela del simioResumen
La viruela del simio es una zoonosis de etiología viral causada por virus de la viruela del simio o Monkeypox virus (MPXV) (por su nombre en inglés). MPXV es un virus de ADN de doble cadena de la familia Poxviridae, a la cual pertenece el virus Variola, agente etiológico de la viruela, enfermedad proclamada erradicada en 1980
Descargas
Referencias
Petersen E, Kantele A, Koopmans M, Asogun D, Yinka-Ogunleye A, Ihekweazu C, et al. Human Monkeypox. Epidemiologic and Clinical Characteristics, Diagnosis, and Prevention. 10.1016/j.idc.2019.03.0012019;33:1027-1043. doi: 10.1016/j.idc.2019.03.001.
Consejo Ejecutivo, 97. Prevención y lucha contra las enfermedades transmisibles Erradicación de la viruela: destrucción de las reservas de virus variólico. informe del Director General. Organización Mundial de la Salud; 1995 https://apps.who.int/iris/handle/10665/192975
WHO. The global eradication of smallpox: final report of the Global Commission for the Certification of Smallpox Eradication. Geneva: World Health Organization, 1980. Published online: https://apps.who.int/iris/handle/10665/39253
Hutin YJ, Williams RJ, Malfait P, Pebody R, Loparev VN, Ropp SL, et al. Outbreak of human monkeypox, Democratic Republic of Congo, 1996 to 1997. Emerg Infect Dis. 2001;7(3):434-438. doi:10.3201/eid0703.017311
Ladnyj ID, Ziegler P, Kima E. A human infection caused by monkeypox virus in Basankusu Territory, Democratic Republic of the Congo. Bull World Health Organ. 1972;46(5):593-597.
E’kitiak M. Management of a suspected case of Monkeypox at Vanga Hospital, Kwilu, Republic Democratic of Congo. Texila Int J Med. 2016;4(2):94-102. doi:10.21522/tijmd.2013.04.02.art009
Reynolds MG, Doty JB, McCollum AM, Olson VA, Nakazawa Y. Monkeypox re-emergence in Africa: a call to expand the concept and practice of One Health. Expert Rev Anti Infect Ther. 2019;17(2):129-139. doi:10.1080/14787210.2019.1567330.
Di Giulio DB, Eckburg PB. Human monkeypox: an emerging zoonosis. Lancet Infect Dis. 2004 Jan;4(1):15-25. doi: 10.1016/s1473-3099(03)00856-9. Erratum in: Lancet Infect Dis. 2004 Apr;4(4):251
Falendysz EA, Lopera JG, Doty JB, Nakazawa Y, Crill C, Lorenzsonn F, et al. Characterization of Monkeypox virus infection in African rope squirrels (Funisciurus sp.). PLoS Negl Trop Dis. 2017;11(8):1-23. doi:10.1371/journal.pntd.0005809
Pal M, Mengstie F, Kandi V. Epidemiology, Diagnosis, and Control of Monkeypox Disease: A comprehensive Review. Am J Infect Dis Microbiol. 2017, 5(2), 94-99. doi:10.12691/ajidm-5-2-4.
Breman JG, Kalisa-Ruti, Steniowski MV, Zanotto E, Gromyko AI, Arita I. Human monkeypox, 1970-79. Bull World Health Organ. 1980;58(2):165-82.
OPS. Alerta Epidemiológica Viruela símica en países no endémicos -20 mayo 2022. OPS; 2022. https://www.paho.org/es/documentos/alerta-epidemiologica-viruela-simica-paises-no-endemicos-20-mayo-2022
WHO. Multicounty monkeypox outbreak. WHO; 2022. https://www.who.int/emergencies/disease-outbreak-news/item/2022-DON385
WHO. Multi-country monkeypox outbreak: situation update. WHO; 2022. Accessed: 2022 June 10. https://www.who.int/emergencies/disease-outbreak-news/item/2022-DON390
Argentina.gob.ar. Salud confirma el quinto caso de viruela símica en el país. Comunicado de Prensa Ministerio de Salud; 2022. https://www.argentina.gob.ar/noticias/salud-confirma-el-quinto-caso-de-viruela-simica-en-el-pais.
Ministério da Saúde. Monkeypox. Boletin Epidemiológico de Monkeypox nº 4. Ministério da Saúde; 2022.
Ministerio de Salud y Protección Social. Minsalud e INS confirman tres casos de viruela símica en Colombia. Boletín de Prensa No 367 de 2022. Ministerio de Salud y Protección Social; 2022. Disponible en: https://www.minsalud.gov.co/Paginas/Minsalud-e-INS-confirman-tres-casos-de-viruela-simica-en-Colombia.aspx.
Ministerio de Salud. Ministerio de Salud decreta alerta sanitaria por viruela del mono. Ministerio de Salud; 2022. https://www.minsal.cl/ministerio-de-salud-decreta-alerta-sanitaria-por-viruela-del-mono/
PAHO. Weekly Situation Report on Monkeypox Multi-Country
Outbreak Response - Region of the Americas. PAHO; 2022. https://www.paho.org/en/file/111108/download?token=s-SeOuXb
WHO. Multi-country monkeypox outbreak: situation update. WHO; 2022. https://www.who.int/emergencies/disease-outbreak-news/item/2022-DON396
Beer EM, Rao VB. A systematic review of the epidemiology of human monkeypox outbreaks and implications for outbreak strategy. PLoS Negl Trop Dis. 2019; 13(10): e0007791. Doi : 10.1371/journal.pntd.0007791
WHO. Weekly bulletin on outbreaks and other emergencies. Week 40. WHO; 2020; https://apps.who.int/iris/bitstream/handle/10665/335869/OEW40-280904102020.pdf
Joshua JT, Nlerum PA. A neuro-fussy based model for diagnosis of monkeypox diseases a neuro-fussy based model for diagnosis of monkeypox diseases. Internat J Computer Sci Trends Technol. 2018; 6(2): 1434-153.
Yinka-Ogunleye A, Aruna O, Dalhat M, et al. Outbreak of human monkeypox in Nigeria in 2017–18: A clinical and epidemiological report. Lancet Infect Dis. 2019; 19(8):872-879. doi: 10.1016/S1473-3099(19)30294-4
Faye O, Pratt CB, Faye M, Fall G, Chitty JA, Diagne MM, et al. Correspondence Genomic. Lancet Infect Dis. 2018;3099(18):231117. doi:10.1016/S1473-3099(18)30043-4
Rimoin AW, Kisalu N, Kebela-Ilunga B, Mukaba T, Wright LL, Formenty P, et al. Endemic human monkeypox, Democratic Republic of Congo, 2001-2004. Emerging infectious diseases. 2007; 13(6): 934–937. Doi: 10.3201/eid1306.061540.
Jezek Z, Grab B, Szczeniowski MV, Paluku KM, Mutombo M. Human monkeypox: secondary attack rates. Bull World Health Organ. 1988;66(4):465-470.
Jezek Z, Arita I, Mutombo M, Dunn C, Nakano JH, Szczeniowski M. Four generations of probable person-to-person transmission of human monkeypox. Am J Epidemiol. 1986;123(6):1004-1012. doi:10.1093/oxfordjournals.aje.a114328
Parker S, Nuara A, Buller RML, Schultz DA. Human monkeypox: An emerging zoonotic disease. Future Microbiol. 2007;2(1):17-34. doi:10.2217/17460913.2.1.17
CDC. Monkeypox Virus Infection in the United States and Other Non-endemic Countries—2022. CDCHAN-00466; CDC; 2022. https://emergency.cdc.gov/han/2022/han00466.asp.
Morand A, Delaigue S, Morand JJ. Panorama des poxvirus: émergence du monkeypox. Médecine Santé Tropicales. 2017; 27(1): 29-39. doi:10.1684/mst.2017.0653
Kabuga AI, el Zowalaty ME. A review of the monkeypox virus and a recent outbreak of skin rash disease in Nigeria. J Medical Virol. 2019; 91(4): 533-540 doi:10.1002/jmv.25348
Kalthan E, Tenguere J, Ndjapou SG, Koyazengbe TA, Mbomba J, Marada RM, et al. Investigation of an outbreak of monkeypox in an area occupied by armed groups, Central African Republic. Med Mal Infect. 2018; 48(4): 263-268. doi:10.1016/j.medmal.2018.02.010
Yinka-Ogunleye A, Aruna O, Ogoina D, Aworabhi N, Eteng W, Badaru S, et al. Reemergence of human monkeypox in Nigeria, 2017. Emerg Infect Dis. 2018; 24(6): 1149-1151. doi:10.3201/eid2406.180017
Reynolds MG, Mccollum AM, Nguete B, Lushima RS, Petersen BW. Improving the care and treatment of monkeypox patients in low-resource settings : applying evidence from contemporary biomedical and smallpox biodefense research. Viruses. 2017; 9(12):380. doi: 10.3390/v9120380.
Nolen LD, Osadebe L, Katomba J, Likofata J, Mukadi D, Monroe B, et al. Introduction of Monkeypox into a Community and Household : Risk Factors and Zoonotic Reservoirs in the Democratic Republic of the Congo. Am J Trop Med Hyg. 2015; 93(2): 410-5. doi: 10.4269/ajtmh.15-0168.
Publicado
Versiones
- 2022-07-03 (2)
- 2022-07-03 (1)
Número
Sección
Licencia
Derechos de autor 2022 Interdisciplinary Journal of Epidemiology and Public Health
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-SinDerivadas 4.0.
-
Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
-
NonCommercial — You may not use the material for commercial purposes.
-
NoDerivatives — If you remix, transform, or build upon the material, you may not distribute the modified material.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
